-
公开(公告)号：US11331418B2
公开(公告)日：2022-05-17
申请号：US17003361
申请日：2020-08-26
IPC分类号： A61L31/10 , A61L31/14 , A61L31/16 , C08L29/04 , C08L39/06 , C09D131/04 , A61K31/7076 , A61K45/06
摘要： The present invention relates to compositions and methods to provide continuous and controlled release of therapeutic agent(s) during a procedure such as an interventional vascular procedure, e.g., to reduce acute and chronic complications and improve outcomes.
-
公开(公告)号：US08771310B2
公开(公告)日：2014-07-08
申请号：US12514189
申请日：2008-05-28
IPC分类号： A61M29/00
CPC分类号： A61L31/16 , A61L31/10 , A61L2300/416 , A61L2300/432 , A61L2300/80
摘要： The present invention relates to compositions and methods for improving outcomes in vascular interventional procedures. In particular, the present invention relates to compositions and methods for improving outcomes in vascular interventional procedures using an anti-no-reflow guide wire that attenuates the “no-reflow” phenomenon that is associated with negative outcomes.
摘要翻译： 本发明涉及用于改善血管介入程序结局的组合物和方法。 特别地，本发明涉及使用抗 - 无回流引导线来改善血管介入手术方法的结果的组合物和方法，所述导引线减弱与否定结果相关的“无回流”现象。
-
公开(公告)号：US20100036411A1
公开(公告)日：2010-02-11
申请号：US12514189
申请日：2008-05-28
IPC分类号： A61M29/00 , C07H19/16 , C08F251/00
CPC分类号： A61L31/16 , A61L31/10 , A61L2300/416 , A61L2300/432 , A61L2300/80
摘要： The present invention relates to compositions and methods for improving outcomes in vascular interventional procedures. In particular, the present invention relates to compositions and methods for improving outcomes in vascular interventional procedures using an anti-no-reflow guide wire that attenuates the “no-reflow” phenomenon that is associated with negative outcomes.
摘要翻译： 本发明涉及用于改善血管介入程序结局的组合物和方法。 特别地，本发明涉及使用抗 - 无回流引导线来改善血管介入手术方法的结果的组合物和方法，所述导引线减弱与否定结果相关的“无回流”现象。
-
公开(公告)号：US20220288284A1
公开(公告)日：2022-09-15
申请号：US17734889
申请日：2022-05-02
摘要： The present invention relates to compositions and methods to provide continuous and controlled release of therapeutic agent(s) during a procedure such as an interventional vascular procedure, e.g., to reduce acute and chronic complications and improve outcomes.
-
公开(公告)号：US20210060215A1
公开(公告)日：2021-03-04
申请号：US17003361
申请日：2020-08-26
摘要： The present invention relates to compositions and methods to provide continuous and controlled release of therapeutic agent(s) during a procedure such as an interventional vascular procedure, e.g., to reduce acute and chronic complications and improve outcomes. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
-
公开(公告)号：US5206222A
公开(公告)日：1993-04-27
申请号：US704058
申请日：1991-05-22
申请人： Mervyn B. Forman , Edwin K. Jackson
发明人： Mervyn B. Forman , Edwin K. Jackson
IPC分类号： A61K31/165 , A61K31/167 , A61K31/70 , A61P9/00 , C07H19/067
CPC分类号： A61K31/70
摘要： This invention relates to a method to treat a heart attack victim to reduce heart muscle damage. In particular, the invention relates to a metGrant StatementThis research was supported in part by the National Institute of Health, Grant R01 HL40892-01.
摘要翻译： 本发明涉及一种治疗心脏病发作受害者以减少心肌损伤的方法。 特别地，本发明涉及一种减少心肌再灌注损伤的方法，通过选择性施用非低血压量的选择性激活腺苷-1受体的化合物，选择性激活腺苷-2受体或腺苷的化合物，全部在存在 有效量的利多卡因。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.015 秒)